Ayako Nishio

Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga

Ryo Inoüe, Ayako Nishio, Yoichi Fukushima et al. · British Journal of Dermatology · 2007 · 66 citations

Life Sciences, Immunology, Microbiology +15

ILDR1 null mice, a model of human deafness DFNB42, show structural aberrations of tricellular tight junctions and degeneration of auditory hair cells

Eva L. Morozko, Ayako Nishio, Neil J. Ingham et al. · Human Molecular Genetics · 2014 · 59 citations · Full text

Medicine, Molecular Genetics, Neuroscience +17

Slc26a4 expression prevents fluctuation of hearing in a mouse model of large vestibular aqueduct syndrome

Ayako Nishio, Taku Ito, Hui Cheng et al. · Neuroscience · 2016 · 40 citations · Full text

Medicine, Molecular Genetics, Neuroscience +10

Primary administration of<i>Lactobacillus johnsonii</i>NCC533 in weaning period suppresses the elevation of proinflammatory cytokines and CD86 gene expressions in skin lesions in NC/Nga mice

Ryo Inoüe, Mai Otsuka, Ayako Nishio et al. · FEMS Immunology & Medical Microbiology · 2007 · 37 citations · Full text

Life Sciences, Immunology, Microbiology +17

Progressive irreversible hearing loss is caused by stria vascularis degeneration in an Slc26a4-insufficient mouse model of large vestibular aqueduct syndrome

Taku Ito, Ayako Nishio, Philine Wangemann et al. · Neuroscience · 2015 · 34 citations · Full text

Medicine, Neuroscience, Otolaryngology +17